Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Market Psychology/ Fear / Stupidity
View:
Post by EternalPonzi on Jan 15, 2020 9:16am

Market Psychology/ Fear / Stupidity

This is very bullish. https://rivertonroll.com/news/2020/01/15/acasti-pharma-cveacst-given-news-sentiment-score-of-4-00.html No one seems to be giving the 'snippet' attached to the press release much rational analysis. https://ml.globenewswire.com/1.0/snippet/369/eng#lg=1&slide=0 For argument's sake, lets just imagine if the Placebo result as depicted in the graph had been more in-line with past studies, somewhere in the -10% - 0% range, and leave the Active results as is. What would the market reaction have likely been then? I think we can all surmise that very easily. For those of you feeling extreme buyers regret, especially if you were a Nov - early Jan buyer remember this; there was no way one could have predicted that the placebo group results would be so unusual. The only logical explanation is that an error in data analysis occurred especially as we now know in at least 5 of the sites. Selling your stake during the panic on Monday was probably an unwise decision - but many had their stop losses triggered. It is obvious that the drug clearly works and if you purchased shares in the past few months with conviction and a belief that the product is likely sound and are still mulling whether to liquidate them reflect back on your original conviction. Look at that graph again carefully, as well as the other results over the past few years. Yes, the greedy day traders and short sellers will cause a high beta for the next several trading sessions but regardless of what negative news continues to be retransmitted continue to remind yourself of the actual facts and act sensibly. Have conviction in whatever informed decision you make (goes for anything in life) and you will likely be rewarded.
Comment by panda55 on Jan 15, 2020 1:49pm
IT SEEMS THe issue is one of DHA  diminishing the effectiveness of EPA. And the statin usage on the placebo can't be quantified. So no matter what ,the info has to be rechecked and for sure more testing even at best.    so ACST is on hold for now. Another example of why to be careful in the market. We are the target of MM's   to get their butt's covered.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities